Curaleaf Completes Buyout of Remaining Stake in Germany’s Four 20 Pharma – PR Newswire
Curaleaf Completes Buyout of Remaining Stake in Germany's Four 20 Pharma PR Newswire Source: news.google.com
Pharma and Biotech
Pharma and Biotech
Curaleaf Completes Buyout of Remaining Stake in Germany’s Four 20 Pharma – PR Newswire
Curaleaf Completes Buyout of Remaining Stake in Germany's Four 20 Pharma PR Newswire Source: news.google.com
Pharma and Biotech
PharmaCorp to Acquire Eight Pharmacies and Provides Acquisition Pipeline Update – GlobeNewswire
PharmaCorp to buy Eight Pharmacies and Provides buyout Pipeline Update GlobeNewswire Source: news.google.com
Pharma and Biotech
LEO Pharma Bolsters Rare Skin Disease Focus Through Acquisition of Replay Gene Therapy Platform – Business Wire
LEO Pharma Bolsters Rare Skin Disease Focus Through buyout of Replay Gene Therapy Platform Business Wire Source: news.google.com
Pharma and Biotech
Chiesi Group to Acquire KalVista Pharmaceuticals, Expanding its Global Rare Disease Portfolio – Business Wire
Chiesi Group to buy KalVista Pharmaceuticals, Expanding its Global Rare Disease Portfolio Business Wire Source: news.google.com
Pharma and Biotech
Ligand Pharma to acquire fellow biotech royalty rights buyer XOMA for $739 million – Reuters
Ligand Pharma to buy fellow biotech royalty rights buyer XOMA for $739 million Reuters Source: news.google.com
Pharma and Biotech
Sun Pharma signs Definitive Agreement to Acquire Organon – Business Wire
Sun Pharma signs Definitive pact to buy Organon Business Wire Source: news.google.com
Pharma and Biotech
Servier completes the acquisition of Day One Biopharmaceuticals – PR Newswire
Servier completes the buyout of Day One Biopharmaceuticals PR Newswire Source: news.google.com
Pharma and Biotech
Kashiv BioSciences Agrees to Be Acquired by Amneal Pharmaceuticals to Create a Fully Integrated Global Biosimilar Leader – Business Wire
Kashiv BioSciences Agrees to Be bought by Amneal Pharmaceuticals to Create a Fully Integrated Global Biosimilar Leader Business Wire Source: news.google.com
Pharma and Biotech
Asahi Kasei Completes Acquisition of Aicuris to Advance Its Global Pharmaceutical Strategy – Business Wire
Asahi Kasei Completes buyout of Aicuris to Advance Its Global Pharmaceutical Strategy Business Wire Source: news.google.com